ADMA

Adma Biologics Stock Analysis

AI Rating

Good
  • Quality7/10
  • Growth↑ 9/10
  • Value↓ 2/10
Adma Biologics sales and earnings growth
ADMA Growth
Great
  • Revenue Y/Y↑ 19.63%
  • EPS Y/Y↓ -27.06%
  • FCF Y/Y↓ -74.81%
Adma Biologics gross and profit margin trends
ADMA Profitability
Great
  • Gross margin ↑ 57.40%
  • EPS margin↑ 28.80%
  • ROIC 5Y↑ 18.39%
Adma Biologics net debt vs free cash flow
ADMA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 26.7

Adma Biologics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗